Generic Name and Formulations:
Clindamycin (as phosphate) 1.2%, benzoyl peroxide 3.75%; gel.
Bausch Health Companies Inc.
Indications for ONEXTON:
Apply a pea-sized amount once daily.
History of regional enteritis, ulcerative or antibiotic-associated colitis.
Avoid eyes, mouth, lips, mucous membranes, broken skin, sun, UV light. Discontinue if significant diarrhea occurs. Pregnancy (Cat.C). Nursing mothers: not recommended.
Lincosamide antibiotic + antibacterial/keratolytic.
Additive irritation with other topical agents. Avoid erythromycin-containing products. Caution with other neuromuscular blocking agents.
Burning sensation, contact dermatitis, pruritus, rash; colitis (may be fatal).
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- Clinical Applications of Liquid Biopsies in Cancer
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Radical Prostatectomy Compared With Watchful Waiting in Localized Prostate Cancer
- Investigational Antiandrogen Drug Delays Metastasis in CRPC
- Treatment Guidelines in Cancer: Assessing Industry Influence on Recommendations
- American Society of Breast Surgeons Recommends Genetic Testing for All Patients With Breast Cancer
- No Benefit Seen From HSCT in Hypodiploid B-ALL
- Patients With CP-CML Deemed Less Likely to Continue Taking Generic Imatinib
- Opinion: Understanding the FDA's Take on Cannabidiol